| Date Filed | Type | Description |
| 06/12/2023 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.88, valued at
$69.1k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $7.8, valued at
$195k
|
|
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/14/2022 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 7,250 shares
@ $0
Disposed/sold 25,000 options to buy
@ $39.5, valued at
$987.5k
Disposed/sold 8,375 options to buy
@ $25.35, valued at
$212.3k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 09/16/2022 |
4
| WIGGANS THOMAS G (CEO) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Granted 450,000 options to buy
@ $2.98, valued at
$1.3M
|
|
| 06/13/2022 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $3.84, valued at
$92.2k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| WIGGANS THOMAS G (CEO) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Granted 985,000 options to buy
@ $6.36, valued at
$6.3M
|
|
| 03/04/2022 |
3
| WIGGANS THOMAS G (CEO) has filed a Form 3 on PARDES BIOSCIENCES, INC. |
| 01/27/2022 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 67,000 options to buy
@ $2.94, valued at
$197k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 10,000 options to buy
@ $21.03, valued at
$210.3k
|
|
| 04/05/2021 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $4.63, valued at
$370.4k
|
|
| 04/05/2021 |
3
| WIGGANS THOMAS G (Director) has filed a Form 3 on CymaBay Therapeutics, Inc. |
| 09/09/2020 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Granted 25,000 options to buy
@ $39.5, valued at
$987.5k
|
|
| 09/09/2020 |
3
| WIGGANS THOMAS G (Director) has filed a Form 3 on Forma Therapeutics Holdings, Inc. |
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2019 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Gifted 5,000 shares
@ $0
Paid exercise price by delivering 4,463 shares
@ $7.91, valued at
$35.3k
Paid exercise price by delivering 3,719 shares
@ $7.91, valued at
$29.4k
Bought 23,419 shares
@ $8.54, valued at
$200k
Exercised 9,000 restricted stock units
@ $0
Exercised 7,500 restricted stock units
@ $0 |
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2018 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Paid exercise price by delivering 865 shares
@ $9.58, valued at
$8.3k
Paid exercise price by delivering 3,113 shares
@ $9.58, valued at
$29.8k
Exercised 2,500 restricted stock units
@ $0
Exercised 9,000 restricted stock units
@ $0 |
|
| 07/09/2018 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Bought 12,000 shares
@ $9.9959, valued at
$120k
|
|
| 07/02/2018 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Bought 13,780 shares
@ $8.7081, valued at
$120k
|
|
| 06/25/2018 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Bought 12,150 shares
@ $9.8425, valued at
$119.6k
|
|
| 06/18/2018 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Bought 11,875 shares
@ $10.1014, valued at
$120k
|
|
| 05/16/2018 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $0.986, valued at
$9.9k
|
|
| 02/16/2018 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 150,000 options to buy
@ $28.25, valued at
$4.2M
Granted 25,000 restricted stock units
@ $0 |
|
| 12/22/2017 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $1.218, valued at
$6.1k
|
|
| 12/15/2017 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Sold 5,000 shares
@ $27.5131, valued at
$137.6k
Exercised 5,000 options to buy
@ $0.986, valued at
$4.9k
|
|
| 11/03/2017 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc. |
| 10/11/2017 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Sold 5,000 shares
@ $27.5212, valued at
$137.6k
Exercised 5,000 options to buy
@ $0.986, valued at
$4.9k
|
|
| 09/19/2017 |
4
| WIGGANS THOMAS G (CEO & Chairman of the Board) has filed a Form 4 on Dermira, Inc.|
Txns:
| Sold 9,500 shares
@ $27.509, valued at
$261.3k
Exercised 9,500 options to buy
@ $0.986, valued at
$9.4k
|
|
|